Home/Filings/5/0001445815-23-000004
5//SEC Filing

PLATT DAVID 5

Accession 0001445815-23-000004

CIK 0001445815other

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 2:00 PM ET

Size

10.4 KB

Accession

0001445815-23-000004

Insider Transaction Report

Form 5
Period: 2022-12-31
PLATT DAVID
DirectorCEO10% Owner
Transactions
  • Discretionary Transaction

    common

    2022-12-31$0.00/sh+1,900,266$3,8014,097,831 total(indirect: by NDPD Pharma, Inc.)
  • Gift

    warrant

    2022-05-13$0.36/sh122,000$43,9200 total(indirect: by NDPD Pharma, Inc.)
    Exercise: $2.00From: 2019-10-23Exp: 2024-10-23common (122,000 underlying)
  • Gift

    common

    2020-01-07+0411,300 total(indirect: By Spouse)
  • Award

    common

    2018-09-21+043,027,274 total
Footnotes (1)
  • [F1]Management ownership in BIXT by NDPD Pharma, Inc. is consolidated under indirect ownership within Davis Platt's filing

Issuer

BIOXYTRAN, INC

CIK 0001445815

Entity typeother

Related Parties

1
  • filerCIK 0001166440

Filing Metadata

Form type
5
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 2:00 PM ET
Size
10.4 KB